PMID- 36569206 OWN - NLM STAT- MEDLINE DCOM- 20221227 LR - 20230110 IS - 2235-2988 (Electronic) IS - 2235-2988 (Linking) VI - 12 DP - 2022 TI - Localization and potential role of prostate microbiota. PG - 1048319 LID - 10.3389/fcimb.2022.1048319 [doi] LID - 1048319 AB - INTRODUCTION: We aimed to clarify the presence and localization of the prostate microbiota and examine its association with benign prostate enlargement (BPE). METHODS: The microbiota of prostate tissues and catheterized urine from 15 patients were analyzed by 16S metagenomic analysis and compared to show that the prostate microbiota was not a contaminant of the urinary microbiota. Fluorescence in situ hybridization (FISH) and in situ hybridization (ISH) using the specific probe for eubacteria was performed on prostate tissue to show the localization of bacteria in the prostate. The BPE group was defined as prostate volume >/=30 mL, and the non-BPE group as prostate volume <30 mL. The microbiota of the two groups were compared to clarify the association between prostate microbiota and BPE. RESULTS: Faith's phylogenetic diversity index of prostate tissue was significantly higher than that of urine (42.3+/-3.8 vs 25.5+/-5.6, P=0.01). Principal coordinate analysis showed a significant difference between the microbiota of prostate tissue and catheterized urine (P<0.01). FISH and ISH showed the presence of bacteria in the prostatic duct. Comparison of prostate microbiota between the BPE and non-BPE groups showed that the Chao1 index of the BPE group was significantly lower than that of the latter [142 (50-316) vs 169 (97-665), P=0.047] and the abundance of Burkholderia was significantly higher in the BPE group than in the latter. CONCLUSIONS: We demonstrated that the prostate microbiota was located in the prostatic duct and reduced diversity of prostate microbiota was associated with BPE, suggesting that prostate microbiota plays a role in BPE. CI - Copyright (c) 2022 Okada, Takezawa, Tsujimura, Imanaka, Kuribayashi, Ueda, Hatano, Fukuhara, Kiuchi, Fujita, Motooka, Nakamura, Koyama, Shimada and Nonomura. FAU - Okada, Koichi AU - Okada K AD - Department of Urology, Osaka University of Graduate School of Medicine, Suita, Japan. FAU - Takezawa, Kentaro AU - Takezawa K AD - Department of Urology, Osaka University of Graduate School of Medicine, Suita, Japan. FAU - Tsujimura, Go AU - Tsujimura G AD - Department of Urology, Osaka University of Graduate School of Medicine, Suita, Japan. FAU - Imanaka, Takahiro AU - Imanaka T AD - Department of Urology, Osaka University of Graduate School of Medicine, Suita, Japan. FAU - Kuribayashi, Sohei AU - Kuribayashi S AD - Department of Urology, Osaka University of Graduate School of Medicine, Suita, Japan. FAU - Ueda, Norichika AU - Ueda N AD - Department of Urology, Osaka University of Graduate School of Medicine, Suita, Japan. FAU - Hatano, Koji AU - Hatano K AD - Department of Urology, Osaka University of Graduate School of Medicine, Suita, Japan. FAU - Fukuhara, Shinichiro AU - Fukuhara S AD - Department of Urology, Osaka University of Graduate School of Medicine, Suita, Japan. FAU - Kiuchi, Hiroshi AU - Kiuchi H AD - Department of Urology, Osaka University of Graduate School of Medicine, Suita, Japan. FAU - Fujita, Kazutoshi AU - Fujita K AD - Department of Urology, Faculty of Medicine, Kindai University Hospital, Osakasayama, Japan. FAU - Motooka, Daisuke AU - Motooka D AD - Department of Infection Metagenomics, Genome Information Research Center, Osaka University Research Institute for Microbial Diseases, Suita, Japan. FAU - Nakamura, Shota AU - Nakamura S AD - Department of Infection Metagenomics, Genome Information Research Center, Osaka University Research Institute for Microbial Diseases, Suita, Japan. FAU - Koyama, Yoshihisa AU - Koyama Y AD - Department of Neuroscience and Cell Biology, Osaka University Graduate School of Medicine, Suita, Japan. FAU - Shimada, Shoichi AU - Shimada S AD - Department of Neuroscience and Cell Biology, Osaka University Graduate School of Medicine, Suita, Japan. FAU - Nonomura, Norio AU - Nonomura N AD - Department of Urology, Osaka University of Graduate School of Medicine, Suita, Japan. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20221207 PL - Switzerland TA - Front Cell Infect Microbiol JT - Frontiers in cellular and infection microbiology JID - 101585359 SB - IM MH - Humans MH - Male MH - *Prostate MH - In Situ Hybridization, Fluorescence MH - Phylogeny MH - *Prostatic Hyperplasia/complications PMC - PMC9768196 OTO - NOTNLM OT - beneign prostate hyperplasia OT - benign prostate enlargement OT - in situ hybridization OT - microbiome OT - microbiota OT - prostate COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2022/12/27 06:00 MHDA- 2022/12/28 06:00 PMCR- 2022/01/01 CRDT- 2022/12/26 04:08 PHST- 2022/09/19 00:00 [received] PHST- 2022/11/09 00:00 [accepted] PHST- 2022/12/26 04:08 [entrez] PHST- 2022/12/27 06:00 [pubmed] PHST- 2022/12/28 06:00 [medline] PHST- 2022/01/01 00:00 [pmc-release] AID - 10.3389/fcimb.2022.1048319 [doi] PST - epublish SO - Front Cell Infect Microbiol. 2022 Dec 7;12:1048319. doi: 10.3389/fcimb.2022.1048319. eCollection 2022.